PL336847A1 - Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability - Google Patents
Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailabilityInfo
- Publication number
- PL336847A1 PL336847A1 PL98336847A PL33684798A PL336847A1 PL 336847 A1 PL336847 A1 PL 336847A1 PL 98336847 A PL98336847 A PL 98336847A PL 33684798 A PL33684798 A PL 33684798A PL 336847 A1 PL336847 A1 PL 336847A1
- Authority
- PL
- Poland
- Prior art keywords
- improved
- sulphate
- oral administration
- protease inhibitor
- hiv protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL336847A1 true PL336847A1 (en) | 2000-07-17 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98336847A PL336847A1 (en) | 1997-05-29 | 1998-05-26 | Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (en) |
| JP (1) | JP3267632B2 (en) |
| KR (1) | KR20010013042A (en) |
| CN (1) | CN1257497A (en) |
| AU (1) | AU730245B2 (en) |
| BG (1) | BG103923A (en) |
| BR (1) | BR9809498A (en) |
| CA (1) | CA2291086A1 (en) |
| EA (1) | EA199901095A1 (en) |
| EE (1) | EE9900543A (en) |
| HR (1) | HRP980283A2 (en) |
| HU (1) | HUP0004621A3 (en) |
| ID (1) | ID23858A (en) |
| IL (1) | IL132779A0 (en) |
| IS (1) | IS5240A (en) |
| NO (1) | NO995822L (en) |
| PE (1) | PE75099A1 (en) |
| PL (1) | PL336847A1 (en) |
| SK (1) | SK163299A3 (en) |
| TR (1) | TR199902816T2 (en) |
| TW (1) | TW438799B (en) |
| WO (1) | WO1998054178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514910A (en) | 1999-11-24 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | Gamma-hydroxy-2- (fluoroalkylaminocarbonyl) -1-piperazinepentanamides as HIV protease inhibitors |
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0734387B1 (en) * | 1993-12-15 | 2002-04-10 | Merck & Co. Inc. | Hiv protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/en active
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 SK SK1632-99A patent/SK163299A3/en unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/en unknown
- 1998-05-26 IL IL13277998A patent/IL132779A0/en unknown
- 1998-05-26 JP JP50079999A patent/JP3267632B2/en not_active Expired - Fee Related
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/en not_active Application Discontinuation
- 1998-05-26 PL PL98336847A patent/PL336847A1/en unknown
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/en unknown
- 1998-05-26 CN CN98805372A patent/CN1257497A/en active Pending
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 EE EEP199900543A patent/EE9900543A/en unknown
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/en unknown
- 1998-05-26 EA EA199901095A patent/EA199901095A1/en unknown
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/en not_active Application Discontinuation
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/en not_active Application Discontinuation
- 1998-05-28 PE PE1998000432A patent/PE75099A1/en not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/en unknown
- 1999-11-24 BG BG103923A patent/BG103923A/en unknown
- 1999-11-26 NO NO995822A patent/NO995822L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0986554A1 (en) | 2000-03-22 |
| KR20010013042A (en) | 2001-02-26 |
| HRP980283A2 (en) | 1999-08-31 |
| BG103923A (en) | 2000-06-30 |
| IS5240A (en) | 1999-11-09 |
| HUP0004621A3 (en) | 2002-04-29 |
| EA199901095A1 (en) | 2000-08-28 |
| EE9900543A (en) | 2000-06-15 |
| AU7595998A (en) | 1998-12-30 |
| WO1998054178A1 (en) | 1998-12-03 |
| CN1257497A (en) | 2000-06-21 |
| IL132779A0 (en) | 2001-03-19 |
| JP3267632B2 (en) | 2002-03-18 |
| NO995822L (en) | 2000-01-28 |
| TR199902816T2 (en) | 2000-02-21 |
| JP2000513747A (en) | 2000-10-17 |
| TW438799B (en) | 2001-06-07 |
| CA2291086A1 (en) | 1998-12-03 |
| ID23858A (en) | 2000-05-25 |
| SK163299A3 (en) | 2000-07-11 |
| PE75099A1 (en) | 1999-08-11 |
| BR9809498A (en) | 2000-06-20 |
| NO995822D0 (en) | 1999-11-26 |
| HUP0004621A2 (en) | 2002-03-28 |
| AU730245B2 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300952I2 (en) | Peramivir and pharmaceutically acceptable salts thereof | |
| IL137445A0 (en) | Pharmaceutically active compounds and methods of use thereof | |
| IL141155A0 (en) | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin | |
| AP2000001757A0 (en) | Solid oral dosage form comprising a combination of metforming and glibenclamide | |
| HUP0002744A3 (en) | Rapidly releasing and taste-masking pharmaceutical dosage form | |
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| PL341428A1 (en) | Oral pharmacological dosage form of prolonged release type | |
| PL335974A1 (en) | Method of orally administering proteins | |
| EP1024130A4 (en) | Biphenyl-5-alkanoic acid derivatives and use thereof | |
| HUP0003133A2 (en) | Ace-inhibitor nitric salts and use of them for producing pharmaceutical compositions | |
| EP1115396A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| PL335555A1 (en) | Novel compounds - substituted benzamides and therapeutic agent | |
| GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
| GB9924334D0 (en) | Pharmaceutical products and methods of fabrication therefor | |
| EP1154997A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| GB9507415D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
| ZA984967B (en) | Crystal modification of a pharmaceutical agent | |
| CZ2000522A3 (en) | Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof | |
| PL337513A1 (en) | Novel method of obtaining pharmaceutically active compounds and their associated intermediate products | |
| PL336847A1 (en) | Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability | |
| EP0996441A4 (en) | Pharmaceutical compositions of arglabin and arglabin derivatives | |
| HUP0105097A2 (en) | Pharmaceutical mixtures comprising a combination of a profen and other active compounds | |
| HUP0001976A3 (en) | Antiviral protease inhibitors and pharmaceutical compositions | |
| IL108881A0 (en) | Pharmaceutical compositions containing a combination of verapamil and trandolapril | |
| EP1357928A4 (en) | A novel pharmaceutical compound and methods of making and using same |